Search hospitals > Kansas > El Dorado
Cancer Center of Kansas - El Dorado
Claim this profileEl Dorado, Kansas 67042
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Lymphoma
Conducts research for Ovarian Cancer
382 reported clinical trials
2 medical researchers
Summary
Cancer Center of Kansas - El Dorado is a medical facility located in El Dorado, Kansas. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Lymphoma, Ovarian Cancer and other specialties. Cancer Center of Kansas - El Dorado is involved with conducting 382 clinical trials across 412 conditions. There are 2 research doctors associated with this hospital, such as Shaker Dakhil, M.D. and Dennis F. Moore.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
2Lung Cancer
Global LeaderStage II
Stage I
Stage IV
Top PIs
Shaker Dakhil, M.D.Ascension Via Christi Hospitals Wichita6 years of reported clinical research
Expert in Breast Cancer
Expert in Lung Cancer
83 reported clinical trials
170 drugs studied
Dennis F. MooreAscension Via Christi Hospitals Wichita4 years of reported clinical research
Studies Lung Cancer
Studies Breast Cancer
30 reported clinical trials
80 drugs studied
Clinical Trials running at Cancer Center of Kansas - El Dorado
Lung Cancer
Bladder Cancer
Bladder Carcinoma
Breast Cancer
Breast cancer
Kidney Cancer
Multiple Myeloma
Non-Small Cell Lung Cancer
Cancer
Prostate Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Ceralasertib + Durvalumab
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of adding AZD6738 to durvalumab versus durvalumab alone to increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery. AZD6738 may stop the growth of tumor cells and may kill them by blocking some of the enzymes needed for cell growth. Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Adding AZD6738 to durvalumab may increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery.
Recruiting2 awards Phase 310 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cancer Center of Kansas - El Dorado?
Cancer Center of Kansas - El Dorado is a medical facility located in El Dorado, Kansas. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Lymphoma, Ovarian Cancer and other specialties. Cancer Center of Kansas - El Dorado is involved with conducting 382 clinical trials across 412 conditions. There are 2 research doctors associated with this hospital, such as Shaker Dakhil, M.D. and Dennis F. Moore.
Where is Cancer Center of Kansas - El Dorado located?
**Cancer Center of Kansas - El Dorado**
- **Address:** 700 West Central, El Dorado, KS 67042 (Located within Susan B. Allen Memorial Hospital)
- **Contact Number:** (316) 320-9650
Who should I call to ask about financial aid or insurance network?
The Cancer Center of Kansas - El Dorado provides financial assistance through Patient Assistance Counselors in the Business Office. For general financial inquiries, contact the KanCare Ombudsman Office at 1-855-643-8180 or KanCare.Ombudsman@ks.gov. Intermountain Healthcare also offers financial assistance based on family size and gross annual household income.
What insurance does Cancer Center of Kansas - El Dorado accept?
The Cancer Center of Kansas - El Dorado accepts the Secure Hospital Indemnity PlanSM (S-HIP) and the Secure 300 Cancer PlanSM (Secure 300) from Blue Cross and Blue Shield of Kansas. These plans offer cash benefits for hospitalization due to illness or injury and for cancer treatment, supplementing existing health insurance. They are available to Kansas residents with Minimum Essential Coverage, including individual policies, job-based coverage, Medicare, Medicaid, CHIP, TRICARE, and more.
What awards or recognition has Cancer Center of Kansas - El Dorado received?
The Cancer Center of Kansas (CCK), located in El Dorado, has been honored as the Favorite Hospital for Cancer Care in Wichita, Kansas, for the years 2016 and 2018. Its research program, initiated in 1983, is acknowledged by the National Cancer Institute (NCI) as a community-based, nationally recognized research program, now part of the NCI Community Oncology Research Program (NCORP).
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.